Hartl’s research indicates that reduced DNase IL3 activity in Lupus Nephritis (LN) patients is linked to neutralizing anti-DNase IL3 antibodies, which contribute to increased cfDNA accumulation and anti-DNA autoimmunity in SLE (Hartl et al., 2021). The gene discussed is IL3; the disease is lupus nephritis.